{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:53:55Z","timestamp":1795031635451,"version":"4.10.2"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2010447"],"award-info":[{"award-number":["W81XWH2010447"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08345-z","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T03:18:45Z","timestamp":1751339925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A bitopic mTORC inhibitor reverses phenotypes in a tuberous sclerosis complex model"],"prefix":"10.1038","volume":"15","author":[{"given":"Sulagna","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Wolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria A.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan M.","family":"Sokolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Feliciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"8345_CR1","doi-asserted-by":"publisher","unstructured":"Northrup, H. et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr. Neurol. 123 https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.07.011 (2021).","DOI":"10.1016\/j.pediatrneurol.2021.07.011"},{"key":"8345_CR2","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"The European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","unstructured":"The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75, 1305\u20131315. https:\/\/doi.org\/10.1016\/0092-8674(93)90618-Z (1993).","journal-title":"Cell"},{"key":"8345_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M Van Slegtenhorst","year":"1997","unstructured":"Van Slegtenhorst, M. et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277, 805\u2013808. https:\/\/doi.org\/10.1126\/science.277.5327.805 (1997).","journal-title":"Science"},{"key":"8345_CR4","doi-asserted-by":"publisher","unstructured":"Feliciano, D. M. Modeling genetic mosaicism of the mammalian target of rapamycin pathway in the cerebral cortex. Front. Mammal Sci. 2. (2023). https:\/\/doi.org\/10.3389\/fmamm.2023.1231778","DOI":"10.3389\/fmamm.2023.1231778"},{"key":"8345_CR5","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Li, Y., Xu, T. & Guan, K. L. Rheb GTpase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829\u20131834. https:\/\/doi.org\/10.1101\/gad.1110003 (2003).","journal-title":"Genes Dev."},{"key":"8345_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1042\/BJ20021266","volume":"372","author":"A Beugnet","year":"2003","unstructured":"Beugnet, A., Tee, A. R., Taylor, P. M. & Proud, C. G. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. Biochem. J. 372, 555\u2013566. https:\/\/doi.org\/10.1042\/BJ20021266 (2003).","journal-title":"Biochem. J."},{"key":"8345_CR7","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","volume":"11","author":"A Garami","year":"2003","unstructured":"Garami, A. et al. Insulin activation of rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell. 11, 1457\u20131466. https:\/\/doi.org\/10.1016\/S1097-2765(03)00220-X (2003).","journal-title":"Mol. Cell."},{"key":"8345_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/ncb999","volume":"5","author":"Y Zhang","year":"2003","unstructured":"Zhang, Y. et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell. Biol. 5, 578\u2013581. https:\/\/doi.org\/10.1038\/ncb999 (2003).","journal-title":"Nat. Cell. Biol."},{"key":"8345_CR9","doi-asserted-by":"publisher","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR Signaling in Growth, Metabolism, and Disease. Cell 168, 960\u2013976. (2017). https:\/\/doi.org\/10.1016\/j.cell.2017.02.004","DOI":"10.1016\/j.cell.2017.02.004"},{"key":"8345_CR10","doi-asserted-by":"publisher","unstructured":"Feliciano, D. M. et al. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits, (2013). https:\/\/doi.org\/10.1016\/j.ijdevneu.2013.02.008","DOI":"10.1016\/j.ijdevneu.2013.02.008"},{"key":"8345_CR11","doi-asserted-by":"publisher","unstructured":"Feliciano, D. M. The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC) at Frontiers, (2020). https:\/\/doi.org\/10.3389\/fnana.2020.00039","DOI":"10.3389\/fnana.2020.00039"},{"key":"8345_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup, H. et al. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr. Neurol. 49, 243\u2013254. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.08.001 (2013).","journal-title":"Pediatr. Neurol."},{"key":"8345_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1515\/revneuro-2017-0027","volume":"29","author":"DL Chan","year":"2018","unstructured":"Chan, D. L., Calder, T., Lawson, J. A., Mowat, D. & Kennedy, S. E. The natural history of subependymal giant cell Astrocytomas in tuberous sclerosis complex: A review. Rev. Neurosci. 29, 295\u2013301. https:\/\/doi.org\/10.1515\/revneuro-2017-0027 (2018).","journal-title":"Rev. Neurosci."},{"key":"8345_CR14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","volume":"16","author":"MEAPM Adriaensen","year":"2009","unstructured":"Adriaensen, M. E. A. P. M. et al. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur. J. Neurol. 16, 691\u2013696. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02567.x (2009).","journal-title":"Eur. J. Neurol."},{"key":"8345_CR15","doi-asserted-by":"publisher","unstructured":"Fujiwara, S., Takaki, T., Hikita, T. & Nishio, S. Subependymal giant-cell astrocytoma associated with tuberous sclerosis - Do subependymal nodules grow? Child\u2019s Nerv. Syst. 5. (1989). https:\/\/doi.org\/10.1007\/BF00706748","DOI":"10.1007\/BF00706748"},{"key":"8345_CR16","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1172\/JCI96342","volume":"128","author":"P Zordan","year":"2018","unstructured":"Zordan, P. et al. Tuberous sclerosis complex-associated CNS abnormalities depend on hyperactivation of mTORC1 and Akt. J. Clin. Invest. 128, 1688\u20131706. https:\/\/doi.org\/10.1172\/JCI96342 (2018).","journal-title":"J. Clin. Invest."},{"key":"8345_CR17","doi-asserted-by":"publisher","unstructured":"J\u00f3\u017awiak, S., Nabbout, R. & Curatolo, P. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations. Eur. J. Paediatr. Neurol. 17. (2013). https:\/\/doi.org\/10.1016\/j.ejpn.2012.12.008","DOI":"10.1016\/j.ejpn.2012.12.008"},{"key":"8345_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00705","author":"AC Jansen","year":"2019","unstructured":"Jansen, A. C. et al. Clinical characteristics of subependymal giant cell Astrocytoma in tuberous sclerosis complex. Front. Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.00705 (2019).","journal-title":"Front. Neurol."},{"key":"8345_CR19","doi-asserted-by":"publisher","unstructured":"Jansen, A. C. et al. Newly diagnosed and growing subependymal giant cell Astrocytoma in adults with tuberous sclerosis complex: results from the international TOSCA study. Front. Neurol. 10 https:\/\/doi.org\/10.3389\/fneur.2019.00821 (2019).","DOI":"10.3389\/fneur.2019.00821"},{"key":"8345_CR20","doi-asserted-by":"publisher","unstructured":"Ryoo, J. S. et al. Trends in survival and treatment of SEGA: National Cancer Database Analysis. Neuro-Oncology Pract. 8. (2021). https:\/\/doi.org\/10.1093\/nop\/npaa060","DOI":"10.1093\/nop\/npaa060"},{"key":"8345_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","volume":"381","author":"DN Franz","year":"2013","unstructured":"Franz, D. N. et al. Efficacy and safety of everolimus for subependymal giant cell Astrocytomas associated with tuberous sclerosis complex (EXIST-1): A multicentre, randomised, placebo-controlled phase 3 trial. Lancet 381, 125\u2013132. https:\/\/doi.org\/10.1016\/S0140-6736(12)61134-9 (2013).","journal-title":"Lancet"},{"key":"8345_CR22","doi-asserted-by":"publisher","unstructured":"Kotulska, K. et al. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Eur. J. Paediatr. Neurol. 17. (2013). https:\/\/doi.org\/10.1016\/j.ejpn.2013.03.002","DOI":"10.1016\/j.ejpn.2013.03.002"},{"key":"8345_CR23","doi-asserted-by":"publisher","unstructured":"Franz, D. N. & Capal, J. K. MTOR inhibitors in the Pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders, (2017). https:\/\/doi.org\/10.1186\/s13023-017-0596-2","DOI":"10.1186\/s13023-017-0596-2"},{"key":"8345_CR24","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"CC Thoreen","year":"2009","unstructured":"Thoreen, C. C. et al. An ATP-competitive mammalian target of Rapamycin inhibitor reveals Rapamycin-resistant functions of mTORC1. J. Biol. Chem. 284, 8023\u20138032. https:\/\/doi.org\/10.1074\/jbc.M900301200 (2009).","journal-title":"J. Biol. Chem."},{"key":"8345_CR25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1126\/science.1236566","volume":"341","author":"SA Kang","year":"2013","unstructured":"Kang, S. A. et al. mTORC1 phosphorylation sites encode their sensitivity to starvation and Rapamycin. Science 341, 364\u2013373. https:\/\/doi.org\/10.1126\/science.1236566 (2013).","journal-title":"Science"},{"key":"8345_CR26","doi-asserted-by":"publisher","unstructured":"Rodrik-Outmezguine, V. S. et al. Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor. Nature 534 https:\/\/doi.org\/10.1038\/nature17963 (2016).","DOI":"10.1038\/nature17963"},{"key":"8345_CR27","doi-asserted-by":"publisher","unstructured":"Riley, V. A. et al. Tsc2 coordinates neuroprogenitor differentiation. iScience 26, 108442. (2023). https:\/\/doi.org\/10.1016\/j.isci.2023.108442","DOI":"10.1016\/j.isci.2023.108442"},{"key":"8345_CR28","doi-asserted-by":"crossref","unstructured":"Holmberg, J., Riley, V., Sokolov, A., Mukherjee, S. & Feliciano, D. Protocol for Electroporating and Isolating Murine (Sub-) Ventricular Zone Cells for Single Nuclei Omics (Star Protoc, 2024).","DOI":"10.1016\/j.xpro.2024.103095"},{"key":"8345_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fnmol.2022.970357","volume":"15","author":"VA Riley","year":"2022","unstructured":"Riley, V. A., Holmberg, J. C., Sokolov, A. M. & Feliciano, D. M. Tsc2 shapes olfactory bulb granule cell molecular and morphological characteristics. Front. Mol. Neurosci. 15, 19 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"8345_CR30","doi-asserted-by":"publisher","first-page":"15012","DOI":"10.1523\/JNEUROSCI.2248-12.2012","volume":"32","author":"GN Paliouras","year":"2012","unstructured":"Paliouras, G. N. et al. Mammalian target of Rapamycin signaling is a key regulator of the transit-amplifying progenitor pool in the adult and aging forebrain. J. Neurosci. 32, 15012\u201315026. https:\/\/doi.org\/10.1523\/JNEUROSCI.2248-12.2012 (2012).","journal-title":"J. Neurosci."},{"key":"8345_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.celrep.2013.09.017","volume":"5","author":"NW Hartman","year":"2013","unstructured":"Hartman, N. W. et al. MTORC1 targets the translational repressor 4E-BP2, but not S6 kinase 1\/2, to regulate neural stem cell Self-Renewal invivo. Cell. Rep. 5, 433\u2013444. https:\/\/doi.org\/10.1016\/j.celrep.2013.09.017 (2013).","journal-title":"Cell. Rep."},{"key":"8345_CR32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ccell.2017.01.014","volume":"31","author":"QW Fan","year":"2017","unstructured":"Fan, Q. W. et al. A kinase inhibitor targeted to mTORC1 drives regression in glioblastoma. Cancer Cell. 31, 424\u2013435. https:\/\/doi.org\/10.1016\/j.ccell.2017.01.014 (2017).","journal-title":"Cancer Cell."},{"key":"8345_CR33","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/dneu.22392","volume":"76","author":"A Skalecka","year":"2016","unstructured":"Skalecka, A. et al. mTOR kinase is needed for the development and stabilization of dendritic arbors in newly born olfactory bulb neurons. Dev. Neurobiol. 76, 1308\u20131327. https:\/\/doi.org\/10.1002\/dneu.22392 (2016).","journal-title":"Dev. Neurobiol."},{"key":"8345_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/hmg\/ddr511","volume":"21","author":"DM Feliciano","year":"2012","unstructured":"Feliciano, D. M., Quon, J. L., Su, T., Taylor, M. M. & Bordey, A. Postnatal neurogenesis generates heterotopias, olfactory micronodules and cortical infiltration following single-cell TSC1 deletion. Hum. Mol. Genet. 21, 799\u2013810. https:\/\/doi.org\/10.1093\/hmg\/ddr511 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"8345_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa186","author":"AM Sokolov","year":"2020","unstructured":"Sokolov, A. M., Holmberg, J. C. & Feliciano, D. M. The amino acid transporter Slc7a5 regulates the mTOR pathway and is required for granule cell development. Hum. Mol. Genet. https:\/\/doi.org\/10.1093\/hmg\/ddaa186 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"8345_CR36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24523","volume":"78","author":"DN Franz","year":"2015","unstructured":"Franz, D. N. et al. Everolimus for subependymal giant cell astrocytoma: 5-year final analysis. Ann. Neurol. 78, 929\u2013938. https:\/\/doi.org\/10.1002\/ana.24523 (2015).","journal-title":"Ann. Neurol."},{"key":"8345_CR37","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1212\/WNL.0b013e3182815428","volume":"80","author":"DA Krueger","year":"2013","unstructured":"Krueger, D. A. et al. Everolimus long-term safety and efficacy in subependymal giant cell Astrocytoma. Neurology 80, 574\u2013580. https:\/\/doi.org\/10.1212\/WNL.0b013e3182815428 (2013).","journal-title":"Neurology"},{"key":"8345_CR38","doi-asserted-by":"publisher","unstructured":"Bobeff, K. et al. Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis \u2013 Final Results From the EMINENTS Study. Front. Neurol. 12. (2021). https:\/\/doi.org\/10.3389\/fneur.2021.581102","DOI":"10.3389\/fneur.2021.581102"},{"key":"8345_CR39","doi-asserted-by":"publisher","unstructured":"Sasongko, T. H., Ismail, N. F. D. & Zabidi-Hussin, Z. A. M. H. Rapamycin and Rapalogs for tuberous sclerosis complex, (2016). https:\/\/doi.org\/10.1002\/14651858.CD011272.pub2","DOI":"10.1002\/14651858.CD011272.pub2"},{"key":"8345_CR40","doi-asserted-by":"publisher","unstructured":"Crithchley, M. & Earl, C. J. C. Tuberose sclerosis and allied conditions. Brain 55. (1932). https:\/\/doi.org\/10.1093\/brain\/55.3.311","DOI":"10.1093\/brain\/55.3.311"},{"key":"8345_CR41","doi-asserted-by":"publisher","unstructured":"Buccoliero, A. M. et al. Subependymal giant cell astrocytoma (SEGA): Is it an astrocytoma? Morphological, immunohistochemical and ultrastructural study. Neuropathology 29. (2009). https:\/\/doi.org\/10.1111\/j.1440-1789.2008.00934.x","DOI":"10.1111\/j.1440-1789.2008.00934.x"},{"key":"8345_CR42","doi-asserted-by":"publisher","unstructured":"Gelot, A. B. & Represa, A. Progression of Fetal Brain Lesions in Tuberous Sclerosis Complex. Front. Neurosci. 14. (2020). https:\/\/doi.org\/10.3389\/fnins.2020.00899","DOI":"10.3389\/fnins.2020.00899"},{"key":"8345_CR43","doi-asserted-by":"publisher","unstructured":"Eichm\u00fcller, O. L. et al. Amplification of human interneuron progenitors promotes brain tumors and neurological defects. Science 375 https:\/\/doi.org\/10.1126\/science.abf5546 (2022).","DOI":"10.1126\/science.abf5546"},{"key":"8345_CR44","doi-asserted-by":"publisher","unstructured":"Stefansson, K. & Wollmann, R. Distribution of glial fibrillary acidic protein in central nervous system lesions of tuberous sclerosis. Acta Neuropathol. 52 https:\/\/doi.org\/10.1007\/BF00688011 (1980).","DOI":"10.1007\/BF00688011"},{"key":"8345_CR45","doi-asserted-by":"publisher","unstructured":"Stefansson, K. & Wollmann, R. Distribution of the neuronal specific protein, 14-3-2, in central nervous system lesions of tuberous sclerosis. Acta Neuropathol. 53 https:\/\/doi.org\/10.1007\/BF00689991 (1981).","DOI":"10.1007\/BF00689991"},{"key":"8345_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1440-1819.1983.tb00307.x","volume":"37","author":"M Tobo","year":"1983","unstructured":"Tobo, M., Mitsuyama, Y. & Kaku, T. Glial fibrillary acidic protein in tuberous sclerosis. Psychiatry Clin. Neurosci. 37, 95\u2013100. https:\/\/doi.org\/10.1111\/j.1440-1819.1983.tb00307.x (1983).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"8345_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1741-4520.2006.00134.x","volume":"47","author":"M Mizuguchi","year":"2007","unstructured":"Mizuguchi, M. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex. Congenit Anom. (Kyoto). 47, 2\u20138. https:\/\/doi.org\/10.1111\/j.1741-4520.2006.00134.x (2007).","journal-title":"Congenit Anom. (Kyoto)"},{"key":"8345_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms15816","volume":"8","author":"KR Martin","year":"2017","unstructured":"Martin, K. R. et al. The genomic landscape of tuberous sclerosis complex. Nat. Commun. 8, 1\u201313. https:\/\/doi.org\/10.1038\/ncomms15816 (2017).","journal-title":"Nat. Commun."},{"key":"8345_CR49","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.celrep.2017.10.095","volume":"21","author":"JD Blair","year":"2017","unstructured":"Blair, J. D., Hockemeyer, D., Doudna, J. A., Bateup, H. S. & Floor, S. N. Widespread translational remodeling during human neuronal differentiation. Cell. Rep. 21, 2005\u20132016. https:\/\/doi.org\/10.1016\/j.celrep.2017.10.095 (2017).","journal-title":"Cell. Rep."},{"key":"8345_CR50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-019-0888-x","volume":"566","author":"A Baser","year":"2019","unstructured":"Baser, A. et al. Onset of differentiation is post-transcriptionally controlled in adult neural stem cells. Nature 566, 100\u2013104. https:\/\/doi.org\/10.1038\/s41586-019-0888-x (2019).","journal-title":"Nature"},{"key":"8345_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.004","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth. Metabolism Disease. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004 (2017).","journal-title":"Metabolism Disease"},{"key":"8345_CR52","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1523\/JNEUROSCI.1840-12.2013","volume":"33","author":"CA Lafourcade","year":"2013","unstructured":"Lafourcade, C. A. et al. Rheb activation in subventricular zone progenitors leads to heterotopia, ectopic neuronal differentiation, and rapamycin-sensitive olfactory micronodules and dendrite hypertrophy of newborn neurons. J. Neurosci. 33, 2419\u20132431. https:\/\/doi.org\/10.1523\/JNEUROSCI.1840-12.2013 (2013).","journal-title":"J. Neurosci."},{"key":"8345_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/dvg.20271","volume":"45","author":"O Hernandez","year":"2007","unstructured":"Hernandez, O., Way, S., McKenna, J. & Gambello, M. J. Generation of a conditional disruption of the Tsc2 gene. Genesis 45, 101\u2013106. https:\/\/doi.org\/10.1002\/dvg.20271 (2007).","journal-title":"Genesis"},{"key":"8345_CR54","doi-asserted-by":"publisher","DOI":"10.3791\/50197","author":"DM Feliciano","year":"2013","unstructured":"Feliciano, D. M., Lafourcade, C. A. & Bordey, A. Neonatal subventricular zone electroporation. J. Vis. Exp. https:\/\/doi.org\/10.3791\/50197 (2013).","journal-title":"J. Vis. Exp."},{"key":"8345_CR55","doi-asserted-by":"publisher","first-page":"103095","DOI":"10.1016\/j.xpro.2024.103095","volume":"5","author":"JC Holmberg","year":"2024","unstructured":"Holmberg, J. C., Riley, V. A., Sokolov, A. M., Mukherjee, S. & Feliciano, D. M. Protocol for electroporating and isolating murine (sub)ventricular zone cells for single-nuclei omics. STAR. Protoc. 5, 103095. https:\/\/doi.org\/10.1016\/j.xpro.2024.103095 (2024).","journal-title":"STAR. Protoc."},{"key":"8345_CR56","doi-asserted-by":"publisher","unstructured":"Matsuda, T. & Cepko, C. L. Controlled expression of transgenes introduced by in vivo electroporation. Proc. Natl. Acad. Sci. U. S. A. 104. (2007). https:\/\/doi.org\/10.1073\/pnas.0610155104","DOI":"10.1073\/pnas.0610155104"},{"key":"8345_CR57","doi-asserted-by":"publisher","unstructured":"Matsuda, T. & Cepko, C. L. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc. Natl. Acad. Sci. U. S. A. 101. (2004). https:\/\/doi.org\/10.1073\/pnas.2235688100","DOI":"10.1073\/pnas.2235688100"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08345-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08345-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08345-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T03:18:46Z","timestamp":1751339926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08345-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8345"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08345-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6008400\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2025.03.14.636465","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the researchers have no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"20367"}}